All stock lists
Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
Healthcare · Biotechnology
59.03+1.01 (+1.74%)
Insider Score
––Not scored
ARWR Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
ARWR analyst forecast
ARWR analyst consensus
No analyst ratings in the last 3 months.
ARWR 12-month price target
$94.33+59.8% upsideaverage of 3 firms
$109.00High
$74.00Low
Best analysts covering ARWR
No firm covering ARWR has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
ARWR analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| UBS | — | $109.00 | +86.7% | — | 2026-10-15 | |
| Goldman Sachs | — | $74.00 | +10.5% | — | 2026-09-24 | |
| RBC Capital | — | $100.00 | +21.5% | — | 2026-08-31 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.